{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:21:05Z","timestamp":1783455665556,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,10,17]],"date-time":"2010-10-17T00:00:00Z","timestamp":1287273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00540-010-1033-z","type":"journal-article","created":{"date-parts":[[2010,10,16]],"date-time":"2010-10-16T03:22:23Z","timestamp":1287199343000},"page":"893-900","source":"Crossref","is-referenced-by-count":7,"title":["The cellular mechanisms underlying the inhibitory effects of isoflurane and sevoflurane on arginine vasopressin-induced vasoconstriction"],"prefix":"10.1007","volume":"24","author":[{"given":"Manabu","family":"Shimogai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Tokinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,17]]},"reference":[{"key":"1033_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1254\/jphs.CP0070027","volume":"104","author":"K Hirano","year":"2007","unstructured":"Hirano K. Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci. 2007;104:109\u201315.","journal-title":"J Pharmacol Sci"},{"key":"1033_CR2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00000542-200404000-00018","volume":"100","author":"J Yu","year":"2004","unstructured":"Yu J, Tokinaga Y, Ogawa K, Iwahashi S, Hatano Y. Sevoflurane inhibits angiotensin II-induced, protein kinase C-mediated but not Ca2+-elicited contraction of rat aortic smooth muscle. Anesthesiology. 2004;100:879\u201384.","journal-title":"Anesthesiology"},{"key":"1033_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1213\/01.ane.0000265851.37923.ec","volume":"105","author":"A Ishikawa","year":"2007","unstructured":"Ishikawa A, Ogawa K, Tokinaga Y, Uematsu N, Mizumoto K, Hatano Y. The mechanism behind the inhibitory effect of isoflurane on angiotensin II-induced contraction is different from that of sevoflurane. Anesth Analg. 2007;105:97\u2013102.","journal-title":"Anesth Analg"},{"key":"1033_CR4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1213\/ane.0b013e3181ac6d96","volume":"109","author":"F Qi","year":"2009","unstructured":"Qi F, Ogawa K, Tokinaga Y, Uematsu N, Minonishi T, Hatano Y. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation. Anesth Analg. 2009;109:412\u20137.","journal-title":"Anesth Analg"},{"key":"1033_CR5","doi-asserted-by":"crossref","first-page":"F545","DOI":"10.1152\/ajprenal.00150.2002","volume":"288","author":"RW Fallet","year":"2005","unstructured":"Fallet RW, Ikenaga H, Bast JP, Carmines PK. Relative contribution of Ca2+ mobilization and influx in renal arteriolar response to arginine vasopressin. Am J Physiol Renal Physiol. 2005;288:F545\u201351.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1033_CR6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1152\/japplphysiol.00825.2006","volume":"102","author":"KK Henderson","year":"2007","unstructured":"Henderson KK, Byron KL. Vasopressin-induced vasocostriction: two concentration-dependent signaling pathways. J Appl Physiol. 2007;102:1402\u20139.","journal-title":"J Appl Physiol"},{"key":"1033_CR7","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ndt\/gfg291","volume":"18","author":"A Cavarape","year":"2003","unstructured":"Cavarape A, Bauer J, Bartoli E, Endlich K, Parekh N. Effects of angiotensin II arginine vasopressin and thromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant. 2003;18:1764\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1033_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1472-8206.2003.00221.x","volume":"18","author":"JO Streefkerk","year":"2004","unstructured":"Streefkerk JO, Hoogaars WMH, Christoffels VM, Sand C, Pfaffendorf M, Peters SLM, Van Zwieten PA. Vasopressin-induced vasoconstriction is dependent on MAPKerk1\/2 phosphorylation. Fundam Clin Pharmacol. 2004;18:45\u201350.","journal-title":"Fundam Clin Pharmacol"},{"key":"1033_CR9","first-page":"4","volume":"63","author":"DT Ouden Den","year":"2005","unstructured":"Den Ouden DT, Meinders AE. Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review. Neth J Med. 2005;63:4\u201313.","journal-title":"Neth J Med"},{"key":"1033_CR10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0003-4975(02)04408-9","volume":"75","author":"DL Morales","year":"2003","unstructured":"Morales DL, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, Landry DW, Oz MC. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75:926\u201330.","journal-title":"Ann Thorac Surg"},{"key":"1033_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0003-4975(99)01197-2","volume":"69","author":"DL Morales","year":"2000","unstructured":"Morales DL, Gregg D, Helman DN, Williams MR, Naka Y, Landry DW, Oz MC. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg. 2000;69:102\u20136.","journal-title":"Ann Thorac Surg"},{"key":"1033_CR12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/00000542-200410000-00032","volume":"101","author":"W Schummer","year":"2004","unstructured":"Schummer W, Schummer C, Wippermann J, Fuchs J. Anaphylactic shock: is vasopressin the drug of choice? Anesthesiology. 2004;101:1025\u20137.","journal-title":"Anesthesiology"},{"key":"1033_CR13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03018778","volume":"51","author":"SR Williams","year":"2004","unstructured":"Williams SR, Denault A, Pellerin M, Martineau R. Vasopressin for treatment of shock following aprotinin administration. Can J Anaesth. 2004;51:169\u201372.","journal-title":"Can J Anaesth"},{"key":"1033_CR14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF03016310","volume":"55","author":"L Meng","year":"2008","unstructured":"Meng L, Williams EL. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anaesth. 2008;55:437\u201340.","journal-title":"Can J Anaesth"},{"key":"1033_CR15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1213\/00000539-199609000-00026","volume":"83","author":"H Fujihara","year":"1996","unstructured":"Fujihara H, Fukuda S, Fujihara N, Shimoji K. The effects of halothane on arginine-vasopressin-induced Ca2+ mobilization from the intracellular stores and the receptor-mediated Ca2+ entry from the extracellular space in single cultured smooth muscle cells of rat aorta. Anesth Analg. 1996;83:584\u201390.","journal-title":"Anesth Analg"},{"key":"1033_CR16","first-page":"645","volume":"99","author":"J Yu","year":"2003","unstructured":"Yu J, Ogawa K, Tokinaga Y, Hatano Y. Sevoflurane inhibits guanosine 5\u2032-[\u03b3-thio] triphosphate-stimulated, Rho\/Rho kinase-mediated contraction of rat aortic smooth muscle. Anesthesiology. 2003;99:645\u201351.","journal-title":"Anesthesiology"},{"key":"1033_CR17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76\u201385.","journal-title":"Anal Biochem"},{"key":"1033_CR18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","volume":"96","author":"BM Patel","year":"2002","unstructured":"Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96:576\u201382.","journal-title":"Anesthesiology"},{"key":"1033_CR19","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"MW D\u00fcnser","year":"2003","unstructured":"D\u00fcnser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock, a prospective, randomized, controlled study. Circulation. 2003;107:2313\u20139.","journal-title":"Circulation"},{"key":"1033_CR20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877\u201387.","journal-title":"N Engl J Med"},{"key":"1033_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01596-0","volume":"22","author":"Y Fukata","year":"2001","unstructured":"Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001;22:32\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"1033_CR22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000542-200702000-00026","volume":"106","author":"T Akata","year":"2007","unstructured":"Akata T. General anesthetics and vascular smooth muscle. Direct actions of general anesthetics on cellular mechanisms regulating vascular tone. Anesthesiology. 2007;106:365\u201391.","journal-title":"Anesthesiology"},{"key":"1033_CR23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1399-6576.2005.00699.x","volume":"49","author":"J Yu","year":"2005","unstructured":"Yu J, Mizumoto K, Kakutani T, Hasegawa A, Ogawa K, Hatano Y. Comparison of the effects of isoflurane and sevoflurane on protein tyrosine phosphorylation-mediated vascular contraction. Acta Anaesthesiol Scand. 2005;49:852\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1033_CR24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00003246-200103000-00004","volume":"29","author":"I Tsuneyoshi","year":"2001","unstructured":"Tsuneyoshi I, Yamada H, Kakihara Y, Nakamura M, Nakao Y, Boyle WA 3rd. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29:487\u201393.","journal-title":"Crit Care Med"},{"key":"1033_CR25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.CCM.0000104111.61317.4B","volume":"32","author":"MW D\u00fcnser","year":"2004","unstructured":"D\u00fcnser MW, Hasibeder WR, Wenzel V, Scjwarz S, Ulmer H, Knotzer H, Pajk W, Friesenecker B, Mayr AJ. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Crit Care Med. 2004;32:126\u201371.","journal-title":"Crit Care Med"},{"key":"1033_CR26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjp.0701397","volume":"122","author":"I Noguera","year":"1997","unstructured":"Noguera I, Medina P, Segarra G, Mart\u00ednez MC, Aldasoro M, Vila JM, Lluch S. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric arteries. Br J Pharmacol. 1997;122:431\u20138.","journal-title":"Br J Pharmacol"},{"key":"1033_CR27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1213\/00000539-199903000-00015","volume":"88","author":"Y Hamu","year":"1999","unstructured":"Hamu Y, Kanmura Y, Tsuneyoshi I, Yoshimura N. The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro. Anesth Analg. 1999;88:542\u20138.","journal-title":"Anesth Analg"},{"key":"1033_CR28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00004872-199917050-00011","volume":"17","author":"T Okamura","year":"1999","unstructured":"Okamura T, Ayajiki K, Fujioka H, Toda N. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertens. 1999;17:673\u20138.","journal-title":"J Hypertens"},{"key":"1033_CR29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF03009915","volume":"41","author":"K Nakamura","year":"1994","unstructured":"Nakamura K, Terasako K, Toda H, Miyawaki I, Kakuyama M, Nishiwada M, Hatano Y, Mori K. Mechanisms of inhibition of endothelium-dependent relaxation by halothane, isoflurane, and sevoflurane. Can J Anaesth. 1994;41:340\u20136.","journal-title":"Can J Anaesth"},{"key":"1033_CR30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/BF03018483","volume":"51","author":"J Yu","year":"2004","unstructured":"Yu J, Ogawa K, Tokinaga Y, Iwahashi S, Hatano Y. The vascular relaxing effects of sevoflurane and isoflurane are more important in hypertensive than in normotensive rats. Can J Anaesth. 2004;51:979\u201385.","journal-title":"Can J Anaesth"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-010-1033-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-010-1033-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-010-1033-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:44:00Z","timestamp":1559083440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-010-1033-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,17]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1007\/s00540-010-1033-z","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,17]]}}}